Depo-Provera Contracts

Our Eligibility and Screening Criteria in Depo-Provera Cases

We are knowledgeable about Depo-Provera injury cases and have an experienced team that will help you launch your Depo-Provera campaign. We are experienced at screening clients based on specific eligibility criteria and delivering signed contracts to your law firm. Atraxia Media implements a retaining campaign that will include the following:

• Pre-screening: Our team will take care of the pre-screening procedure and save you valuable time. We will assess each potential client to determine whether they meet your eligibility criteria.
• Screening each case: As we are well aware of the eligibility criteria, we will screen the clients by conducting interviews. Our objective is to get details of each case to differentiate between eligible and ineligible clients.
• Follow up with potential Depo-Provera clients: We follow up with your prospective clients who are likely to qualify for a Depo-Provera claim.
• Providing signed contracts to your law firm: If you work with us, your law firm will receive a constant flow of signed contracts from us. Atraxia Media will be committed to providing you with the Depo-Provera contracts that you need and you will observe a remarkable increase in the volume of clients you receive.
• Conducting in-house marketing campaigns: Our internal intake department receives leads in real-time and we evaluate these based on the eligibility criteria mentioned to us.
• Referring potential Depo-Provera plaintiffs to your law firm: We refer the best clients exclusively to your law firm after analyzing all the aspects.

Women who are eligible to file a Depo-Provera brain tumor claim must meet the following criteria:

• They must have received contraceptive injections like Depo-Provera, Depo-SubQ Provera, or a generic form of these injections (medroxyprogesterone acetate)
• They must have received at least two Depo-Provera injections after the year 1992.
• They must have developed a brain tumor (meningioma) after receiving the above-mentioned contraceptive injections.

If you are a personal injury lawyer, we strongly recommend you to get in touch with Atraxia Media, and we will ensure you will have a good number of Depo-Provera claim-eligible cases. Contact us and we will help your business flourish.

Depo-Provera Facts & History

Known generically as depot-medroxyprogesterone acetate or DMPA, the Depo-Provera injection was approved in 1992 by the FDA for contraceptive use. It is administered as an intramuscular shot by a doctor or injected subcutaneously by the patient at home once every 12 weeks. The injection releases progestin hormone that suppresses ovulation and increases the thickness of the cervical mucus thus preventing fertilization.

Approximately, 1 in 5 women in the US have used Depo-Provera injectable contraceptive due to the convenient dose schedule of four times a year. In 2004, the FDA added a warning to Depo-Provera labeling regarding the potential side effects of loss of bone mineral density. Recently, it has come to light through a study that the Depo-Provera shot can lead to an increased risk of developing intracranial meningioma, medically known as a brain tumor. This type of brain tumor grows slowly and may not be evident for several years. When a person develops a brain tumor, once it increases in size, it can compress parts of the brain and lead to neurological symptoms including:

• Weakness in the legs or arms
• Loss of hearing
• Loss of vision/blurred vision/double vision
• Loss of memory
• Seizures/confusion
• Speaking difficulty
• Loss of smell
• Nausea and vomiting
• Ringing in the ears
• Persistent headaches

The health complications of these brain tumors include impingement of the tumor mass into surrounding nerves and blood vessels leading to serious problems, which require brain surgery.

The most reported Depo-Provera side effect in the FDA database is neoplasm or tumors, as of August 2024. According to the data collected between 1969 and June, 30, 2024, about 20,499 neoplasms were reported. As one of the serious side effects of Depo-Provera injection is brain tumor, injured people are entitled to receive financial compensation by filing claims with the manufacturer.

DEPO-PROVERA BRAIN TUMOR LITIGATION

History:

• October 2024: On October 1, 2024, the first Depo-Provera lawsuit was filed by Kristina Schmidt in the US District Court Northern District of California against Pfizer, the manufacturer of Depo-Provera, alleging her Grade 1 and Grade 2 brain tumor known as a Sylvian fissure meningioma is the result of her prolonged use of Depo-Provera contraceptive injections received between 2005 and 2021 at a Planned Parenthood in San Ramon, California.

The woman accuses the manufacturer of failing to warn of the risk of brain tumor side effects that could be caused by taking Depo-Provera injections. Her claims against the manufacturers include defective design, inadequate testing, and failure to warn.

• March 2024:

In March 2024, a study published in the British Medical Journal (BMJ) reported that women injected with the Depo-Provera shot were at a 5.6-fold higher risk of developing meningioma.